Katana Biopharma Inc., Theratechnologies Inc. - M&A Call Transcript
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to this Theratechnologies' conference call. (Operator Instructions) I would like to remind everyone that this conference call is being recorded today, February 25, 2019, at 8:30 a.m. Eastern Time.
And I would now like to turn the conference over to Mr. Denis Boucher. Mr. Boucher, please go ahead.
Thank you. Welcome. Mr. Luc Tanguay, President and Chief Executive Officer of Theratechnologies; Mr. Philippe Dubuc, Chief Financial Officer; and Christian Marsolais, Senior Vice President and Chief Medical Officer will be the speakers on today's call. A Q&A period open exclusivity to financial analysts will follow their presentation.
Before Mr. Tanguay begins his remarks, I have been asked by Theratechnologies to read the following message regarding forward-looking statements. I would like to remind everyone that Theratechnologies' remarks today contain forward-looking statements about
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
